K. Lüthke

发表

Significance of antibodies to cardiolipin in unselected patients with systemic lupus erythematosus: clinical and laboratory associations

H. Peter, J. Kalden, C. Specker, 2004, Rheumatology International.

Rituximab therapy in patients with refractory dermatomyositis or polymyositis: differential effects in a real-life population.

M. Aringer, S. Kampf, L. Unger, 2014, Rheumatology.

The use of antimalarials in combination with other disease modifying agents in RA--the British experience.

T. Dörner, K. Conrad, K. Lüthke, 1996 .

Systemic lupus erythematosus after heavy exposure to quartz dust in uranium mines: clinical and serological characteristics.

T. Dörner, K. Conrad, K. Frank, 1996, Lupus.

Influence of exogenous atrial natriuretic peptide on the pituitary-adrenal response to corticotropin-releasing hormone and vasopressin in healthy men.

J. Born, H. Fehm, A. Burgemeister, 1998, The Journal of clinical endocrinology and metabolism.

AB0520 Tocilizumab in rheumatoid arthritis – one year interim analysis of the non-interventional ichiban study

M. Aringer, H. Kellner, H. Tony, 2013 .

Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis.

G. Burmester, P. Rudolph, K. Egerer, 2007, Arthritis and rheumatism.

Defective removal of ribonucleotides from DNA promotes systemic autoimmunity.

Martin A. M. Reijns, M. Nöthen, N. Hübner, 2015, The Journal of clinical investigation.

Etanercept in der klinischen Routinebehandlung von Patienten mit rheumatoider Arthritis

K. Göttl, T. Meng, P. Löschmann, 2019, Zeitschrift für Rheumatologie.